The  ||| S:0 E:4 ||| DT
utility  ||| S:4 E:12 ||| NN
of  ||| S:12 E:15 ||| IN
mass  ||| S:15 E:20 ||| JJ
spectrometry-based  ||| S:20 E:39 ||| JJ
proteomic  ||| S:39 E:49 ||| JJ
data  ||| S:49 E:54 ||| NNS
for  ||| S:54 E:58 ||| IN
validation  ||| S:58 E:69 ||| NN
of  ||| S:69 E:72 ||| IN
novel  ||| S:72 E:78 ||| NN
alternative  ||| S:78 E:90 ||| NN
splice  ||| S:90 E:97 ||| NN
forms  ||| S:97 E:103 ||| NNS
reconstructed  ||| S:103 E:117 ||| VBN
from  ||| S:117 E:122 ||| IN
RNA-Seq  ||| S:122 E:130 ||| JJ
data ||| S:130 E:134 ||| NNS
:  ||| S:134 E:136 ||| :
a  ||| S:136 E:138 ||| DT
preliminary  ||| S:138 E:150 ||| JJ
assessment  ||| S:150 E:161 ||| NN
Most  ||| S:161 E:166 ||| RBS
mass  ||| S:166 E:171 ||| JJ
spectrometry  ||| S:171 E:184 ||| NNS
( ||| S:184 E:185 ||| -LRB-
MS ||| S:185 E:187 ||| NNP
)  ||| S:187 E:189 ||| -RRB-
based  ||| S:189 E:195 ||| VBN
proteomic  ||| S:195 E:205 ||| JJ
studies  ||| S:205 E:213 ||| NNS
depend  ||| S:213 E:220 ||| VBP
on  ||| S:220 E:223 ||| IN
searching  ||| S:223 E:233 ||| VBG
acquired  ||| S:233 E:242 ||| VBN
tandem  ||| S:242 E:249 ||| JJ
mass  ||| S:249 E:254 ||| NN
( ||| S:254 E:255 ||| -LRB-
MS ||| S:255 E:257 ||| NNP
/ ||| S:257 E:258 ||| NNP
MS ||| S:258 E:260 ||| NNP
)  ||| S:260 E:262 ||| -RRB-
spectra  ||| S:262 E:270 ||| NN
against  ||| S:270 E:278 ||| IN
databases  ||| S:278 E:288 ||| NN
of  ||| S:288 E:291 ||| IN
known  ||| S:291 E:297 ||| JJ
protein  ||| S:297 E:305 ||| NN
sequences ||| S:305 E:314 ||| NN
.  ||| S:314 E:316 ||| .
In  ||| S:316 E:319 ||| IN
these  ||| S:319 E:325 ||| DT
experiments ||| S:325 E:336 ||| NNS
,  ||| S:336 E:338 ||| ,
however ||| S:338 E:345 ||| RB
,  ||| S:345 E:347 ||| ,
a  ||| S:347 E:349 ||| DT
large  ||| S:349 E:355 ||| JJ
number  ||| S:355 E:362 ||| NN
of  ||| S:362 E:365 ||| IN
high  ||| S:365 E:370 ||| JJ
quality  ||| S:370 E:378 ||| NN
spectra  ||| S:378 E:386 ||| NNS
remain  ||| S:386 E:393 ||| VBP
unassigned ||| S:393 E:403 ||| VBN
.  ||| S:403 E:405 ||| .
These  ||| S:405 E:411 ||| DT
spectra  ||| S:411 E:419 ||| NN
may  ||| S:419 E:423 ||| MD
correspond  ||| S:423 E:434 ||| VB
to  ||| S:434 E:437 ||| TO
novel  ||| S:437 E:443 ||| NN
peptides  ||| S:443 E:452 ||| VBZ
not  ||| S:452 E:456 ||| RB
present  ||| S:456 E:464 ||| VB
in  ||| S:464 E:467 ||| IN
the  ||| S:467 E:471 ||| DT
database ||| S:471 E:479 ||| NN
,  ||| S:479 E:481 ||| ,
especially  ||| S:481 E:492 ||| RB
those  ||| S:492 E:498 ||| DT
corresponding  ||| S:498 E:512 ||| JJ
to  ||| S:512 E:515 ||| TO
novel  ||| S:515 E:521 ||| VB
alternative  ||| S:521 E:533 ||| JJ
splice  ||| S:533 E:540 ||| NNS
( ||| S:540 E:541 ||| -LRB-
AS ||| S:541 E:543 ||| NNP
)  ||| S:543 E:545 ||| -RRB-
forms ||| S:545 E:550 ||| NNS
.  ||| S:550 E:552 ||| .
Recently ||| S:552 E:560 ||| RB
,  ||| S:560 E:562 ||| ,
fast  ||| S:562 E:567 ||| RB
and  ||| S:567 E:571 ||| CC
comprehensive  ||| S:571 E:585 ||| JJ
profiling  ||| S:585 E:595 ||| NN
of  ||| S:595 E:598 ||| IN
mammalian  ||| S:598 E:608 ||| JJ
genomes  ||| S:608 E:616 ||| NNS
using  ||| S:616 E:622 ||| VBG
deep  ||| S:622 E:627 ||| JJ
sequencing  ||| S:627 E:638 ||| NNS
( ||| S:638 E:639 ||| -LRB-
i.e.  ||| S:639 E:644 ||| FW
RNA-Seq ||| S:644 E:651 ||| FW
)  ||| S:651 E:653 ||| -RRB-
has  ||| S:653 E:657 ||| VBZ
become  ||| S:657 E:664 ||| VBN
possible ||| S:664 E:672 ||| JJ
.  ||| S:672 E:674 ||| .
MS-based  ||| S:674 E:683 ||| JJ
proteomics  ||| S:683 E:694 ||| NN
can  ||| S:694 E:698 ||| MD
potentially  ||| S:698 E:710 ||| RB
be  ||| S:710 E:713 ||| VB
used  ||| S:713 E:718 ||| VBN
as  ||| S:718 E:721 ||| IN
an  ||| S:721 E:724 ||| DT
aid  ||| S:724 E:728 ||| NN
for  ||| S:728 E:732 ||| IN
protein-level  ||| S:732 E:746 ||| JJ
validation  ||| S:746 E:757 ||| NN
of  ||| S:757 E:760 ||| IN
novel  ||| S:760 E:766 ||| NN
AS  ||| S:766 E:769 ||| IN
events  ||| S:769 E:776 ||| NNS
observed  ||| S:776 E:785 ||| VBD
in  ||| S:785 E:788 ||| IN
RNA-Seq  ||| S:788 E:796 ||| JJ
data ||| S:796 E:800 ||| NNS
.  ||| S:800 E:802 ||| .
In  ||| S:802 E:805 ||| IN
this  ||| S:805 E:810 ||| DT
work ||| S:810 E:814 ||| NN
,  ||| S:814 E:816 ||| ,
we  ||| S:816 E:819 ||| PRP
have  ||| S:819 E:824 ||| VBP
used  ||| S:824 E:829 ||| VBN
publicly  ||| S:829 E:838 ||| RB
available  ||| S:838 E:848 ||| JJ
mouse  ||| S:848 E:854 ||| NN
tissue  ||| S:854 E:861 ||| NN
proteomic  ||| S:861 E:871 ||| NNS
and  ||| S:871 E:875 ||| CC
RNA-Seq  ||| S:875 E:883 ||| JJ
datasets  ||| S:883 E:892 ||| NN
and  ||| S:892 E:896 ||| CC
have  ||| S:896 E:901 ||| VBP
examined  ||| S:901 E:910 ||| VBN
the  ||| S:910 E:914 ||| DT
feasibility  ||| S:914 E:926 ||| NN
of  ||| S:926 E:929 ||| IN
using  ||| S:929 E:935 ||| VBG
MS  ||| S:935 E:938 ||| NNP
data  ||| S:938 E:943 ||| NNS
for  ||| S:943 E:947 ||| IN
the  ||| S:947 E:951 ||| DT
identification  ||| S:951 E:966 ||| NN
of  ||| S:966 E:969 ||| IN
novel  ||| S:969 E:975 ||| NN
AS  ||| S:975 E:978 ||| IN
forms  ||| S:978 E:984 ||| NNS
by  ||| S:984 E:987 ||| IN
searching  ||| S:987 E:997 ||| VBG
MS ||| S:997 E:999 ||| NNP
/ ||| S:999 E:1000 ||| NNP
MS  ||| S:1000 E:1003 ||| NNP
spectra  ||| S:1003 E:1011 ||| NN
against  ||| S:1011 E:1019 ||| IN
translated  ||| S:1019 E:1030 ||| VBN
mRNA  ||| S:1030 E:1035 ||| JJ
sequences  ||| S:1035 E:1045 ||| NNS
derived  ||| S:1045 E:1053 ||| VBN
from  ||| S:1053 E:1058 ||| IN
RNA-Seq  ||| S:1058 E:1066 ||| JJ
data ||| S:1066 E:1070 ||| NNS
.  ||| S:1070 E:1072 ||| .
A  ||| S:1072 E:1074 ||| DT
significant  ||| S:1074 E:1086 ||| JJ
correlation  ||| S:1086 E:1098 ||| NN
between  ||| S:1098 E:1106 ||| IN
the  ||| S:1106 E:1110 ||| DT
likelihood  ||| S:1110 E:1121 ||| NN
of  ||| S:1121 E:1124 ||| IN
identifying  ||| S:1124 E:1136 ||| VBG
a  ||| S:1136 E:1138 ||| DT
peptide  ||| S:1138 E:1146 ||| NN
from  ||| S:1146 E:1151 ||| IN
MS ||| S:1151 E:1153 ||| NNP
/ ||| S:1153 E:1154 ||| NNP
MS  ||| S:1154 E:1157 ||| NNP
data  ||| S:1157 E:1162 ||| NNS
and  ||| S:1162 E:1166 ||| CC
the  ||| S:1166 E:1170 ||| DT
number  ||| S:1170 E:1177 ||| NN
of  ||| S:1177 E:1180 ||| IN
reads  ||| S:1180 E:1186 ||| NN
in  ||| S:1186 E:1189 ||| IN
RNA-Seq  ||| S:1189 E:1197 ||| JJ
data  ||| S:1197 E:1202 ||| NNS
for  ||| S:1202 E:1206 ||| IN
the  ||| S:1206 E:1210 ||| DT
same  ||| S:1210 E:1215 ||| JJ
gene  ||| S:1215 E:1220 ||| NN
was  ||| S:1220 E:1224 ||| VBD
observed ||| S:1224 E:1232 ||| VBN
.  ||| S:1232 E:1234 ||| .
Based  ||| S:1234 E:1240 ||| VBN
on  ||| S:1240 E:1243 ||| IN
in  ||| S:1243 E:1246 ||| IN
silico  ||| S:1246 E:1253 ||| JJ
experiments ||| S:1253 E:1264 ||| NNS
,  ||| S:1264 E:1266 ||| ,
it  ||| S:1266 E:1269 ||| PRP
was  ||| S:1269 E:1273 ||| VBD
also  ||| S:1273 E:1278 ||| RB
observed  ||| S:1278 E:1287 ||| VBN
that  ||| S:1287 E:1292 ||| IN
only  ||| S:1292 E:1297 ||| RB
a  ||| S:1297 E:1299 ||| DT
fraction  ||| S:1299 E:1308 ||| NN
of  ||| S:1308 E:1311 ||| IN
novel  ||| S:1311 E:1317 ||| NN
AS  ||| S:1317 E:1320 ||| IN
forms  ||| S:1320 E:1326 ||| NNS
identified  ||| S:1326 E:1337 ||| VBN
from  ||| S:1337 E:1342 ||| IN
RNA-Seq  ||| S:1342 E:1350 ||| NNP
had  ||| S:1350 E:1354 ||| VBD
the  ||| S:1354 E:1358 ||| DT
corresponding  ||| S:1358 E:1372 ||| JJ
junction  ||| S:1372 E:1381 ||| NNS
peptide  ||| S:1381 E:1389 ||| VBP
compatible  ||| S:1389 E:1400 ||| JJ
with  ||| S:1400 E:1405 ||| IN
MS ||| S:1405 E:1407 ||| NNP
/ ||| S:1407 E:1408 ||| NNP
MS  ||| S:1408 E:1411 ||| NNP
sequencing ||| S:1411 E:1421 ||| NN
.  ||| S:1421 E:1423 ||| .
The  ||| S:1423 E:1427 ||| DT
number  ||| S:1427 E:1434 ||| NN
of  ||| S:1434 E:1437 ||| IN
novel  ||| S:1437 E:1443 ||| NN
peptides  ||| S:1443 E:1452 ||| NNS
that  ||| S:1452 E:1457 ||| WDT
were  ||| S:1457 E:1462 ||| VBD
actually  ||| S:1462 E:1471 ||| RB
identified  ||| S:1471 E:1482 ||| VBN
from  ||| S:1482 E:1487 ||| IN
MS ||| S:1487 E:1489 ||| NNP
/ ||| S:1489 E:1490 ||| NNP
MS  ||| S:1490 E:1493 ||| NNP
spectra  ||| S:1493 E:1501 ||| NN
was  ||| S:1501 E:1505 ||| VBD
substantially  ||| S:1505 E:1519 ||| RB
lower  ||| S:1519 E:1525 ||| JJR
than  ||| S:1525 E:1530 ||| IN
the  ||| S:1530 E:1534 ||| DT
number  ||| S:1534 E:1541 ||| NN
expected  ||| S:1541 E:1550 ||| VBN
based  ||| S:1550 E:1556 ||| VBN
on  ||| S:1556 E:1559 ||| IN
in  ||| S:1559 E:1562 ||| IN
silico  ||| S:1562 E:1569 ||| JJ
analysis ||| S:1569 E:1577 ||| NN
.  ||| S:1577 E:1579 ||| .
The  ||| S:1579 E:1583 ||| DT
ability  ||| S:1583 E:1591 ||| NN
to  ||| S:1591 E:1594 ||| TO
confirm  ||| S:1594 E:1602 ||| VB
novel  ||| S:1602 E:1608 ||| NN
AS  ||| S:1608 E:1611 ||| IN
forms  ||| S:1611 E:1617 ||| NNS
from  ||| S:1617 E:1622 ||| IN
MS ||| S:1622 E:1624 ||| NNP
/ ||| S:1624 E:1625 ||| NNP
MS  ||| S:1625 E:1628 ||| NNP
data  ||| S:1628 E:1633 ||| NNS
in  ||| S:1633 E:1636 ||| IN
the  ||| S:1636 E:1640 ||| DT
dataset  ||| S:1640 E:1648 ||| JJ
analyzed  ||| S:1648 E:1657 ||| NN
was  ||| S:1657 E:1661 ||| VBD
found  ||| S:1661 E:1667 ||| VBN
to  ||| S:1667 E:1670 ||| TO
be  ||| S:1670 E:1673 ||| VB
quite  ||| S:1673 E:1679 ||| RB
limited ||| S:1679 E:1686 ||| VBN
.  ||| S:1686 E:1688 ||| .
This  ||| S:1688 E:1693 ||| DT
can  ||| S:1693 E:1697 ||| MD
be  ||| S:1697 E:1700 ||| VB
explained  ||| S:1700 E:1710 ||| VBN
in  ||| S:1710 E:1713 ||| IN
part  ||| S:1713 E:1718 ||| NN
by  ||| S:1718 E:1721 ||| IN
low  ||| S:1721 E:1725 ||| JJ
abundance  ||| S:1725 E:1735 ||| NN
of  ||| S:1735 E:1738 ||| IN
many  ||| S:1738 E:1743 ||| JJ
novel  ||| S:1743 E:1749 ||| NN
transcripts ||| S:1749 E:1760 ||| NNS
,  ||| S:1760 E:1762 ||| ,
with  ||| S:1762 E:1767 ||| IN
the  ||| S:1767 E:1771 ||| DT
abundance  ||| S:1771 E:1781 ||| NN
of  ||| S:1781 E:1784 ||| IN
their  ||| S:1784 E:1790 ||| PRP$
corresponding  ||| S:1790 E:1804 ||| JJ
protein  ||| S:1804 E:1812 ||| NN
products  ||| S:1812 E:1821 ||| NNS
falling  ||| S:1821 E:1829 ||| VBG
below  ||| S:1829 E:1835 ||| IN
the  ||| S:1835 E:1839 ||| DT
limit  ||| S:1839 E:1845 ||| NN
of  ||| S:1845 E:1848 ||| IN
detection  ||| S:1848 E:1858 ||| NN
by  ||| S:1858 E:1861 ||| IN
MS ||| S:1861 E:1863 ||| NNP
.  ||| S:1863 E:1865 ||| .
